IGM Biosciences(IGMS) - 2022 Q4 - Earnings Call Transcript

IGM Biosciences, Inc. (NASDAQ:IGMS) Q4 2022 Earnings Conference Call March 30, 2023 4:30 PM ET Company Participants Fred Schwarzer – Chief Executive Officer Misbah Tahir – Chief Financial Officer Chris Takimoto – Chief Medical Officer Mary Beth Harler – President-IGM Autoimmunity and Inflammation Bruce Keyt – Chief Scientific Officer Conference Call Participants Stephen Willey – Stifel Greg Harrison – Bank of America Michael Schmidt – Guggenheim Roger Song – Jefferies Joel Beatty – Baird Noah Eisenberg – J ...